The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats

[1] Bantick RA(2001)The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15 37-46

[2] Deakin JF(1999)5HT antagonists attenuate MK801-impaired radial arm maze performance in rats Neurobiol Learn Mem 71 259-271

[3] Grasby PM(2002)SR46349-B, a 5-HT(2A/2 C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens Neuropsychopharmacology 27 430-441

[4] Boast C(1996)5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia Neuropsychopharmacology 15 442-455

[5] Bartolomeo AC(1997)[3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia Neurochem Int 30 565-574

[6] Morris H(2009)Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia J Mol Neurosci 38 227-235

[7] Moyer JA(2006)Glutamate and schizophrenia: beyond the dopamine hypothesis Cell Mol Neurobiol 26 365-384

[8] Bonaccorso S(2007)F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms Br J Pharmacol 151 266-277

[9] Meltzer HY(2010)F15599, a preferential post-synaptic 5-HT(1A) receptor agonist: activity in models of cognition in comparison with reference 5-HT(1A) receptor agonists Eur Neuropsychopharmacol 20 641-654

[10] Li Z(2007)Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat Behav Brain Res 184 31-38

[1] Bantick RA(2001)The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15 37-46

[2] Deakin JF(1999)5HT antagonists attenuate MK801-impaired radial arm maze performance in rats Neurobiol Learn Mem 71 259-271

[3] Grasby PM(2002)SR46349-B, a 5-HT(2A/2 C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens Neuropsychopharmacology 27 430-441

[4] Boast C(1996)5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia Neuropsychopharmacology 15 442-455

[5] Bartolomeo AC(1997)[3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia Neurochem Int 30 565-574

[6] Morris H(2009)Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia J Mol Neurosci 38 227-235

[7] Moyer JA(2006)Glutamate and schizophrenia: beyond the dopamine hypothesis Cell Mol Neurobiol 26 365-384

[8] Bonaccorso S(2007)F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms Br J Pharmacol 151 266-277

[9] Meltzer HY(2010)F15599, a preferential post-synaptic 5-HT(1A) receptor agonist: activity in models of cognition in comparison with reference 5-HT(1A) receptor agonists Eur Neuropsychopharmacol 20 641-654

[10] Li Z(2007)Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat Behav Brain Res 184 31-38